Arax Advisory Partners’s Aehr Test Systems AEHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$174K Buy
1,744
+25
+1% +$2.29K ﹤0.01% 2414
2026
Q2
$165K Buy
1,719
+1,299
+309% +$119K ﹤0.01% 2381
2026
Q1
$15.6K Sell
420
-414
-50% -$13.2K ﹤0.01% 2229
2025
Q4
$16.8K Buy
+834
New +$20.2K ﹤0.01% 2208
2025
Q3
– Sell
-830
Closed -$10.7K – 3612
2025
Q2
$10.7K Buy
+830
New +$7.9K ﹤0.01% 1930
2025
Q1
– Sell
-398
Closed -$6.62K – 2667
2024
Q4
$6.62K Buy
+398
New +$5.31K ﹤0.01% 1639

Other funds holding AEHR

Arax Advisory Partners's AEHR Position: Q3 2026 in Review

Arax Advisory Partners increased its Aehr Test Systems (AEHR) stake by 1.5% in Q3 2026, buying an estimated $2.29K and bringing the position to 1,744 shares worth $174K. The position accounts for ﹤0.01% of the portfolio, ranked #2414.

Arax Advisory Partners first reported a position in AEHR in Q4 2024 and has held it in 6 quarters since. 174 funds tracked by Wall St. Rank hold AEHR as of Q3 2026.

  • Arax Advisory Partners held 1,744 shares of Aehr Test Systems worth $174K as of Q3 2026.
  • Arax Advisory Partners bought 25 Aehr Test Systems shares in Q3 2026, an estimated $2.29K.
  • Aehr Test Systems made up ﹤0.01% of Arax Advisory Partners's portfolio in Q3 2026, its #2414 holding.
  • Arax Advisory Partners first reported a position in Aehr Test Systems in Q4 2024 and has held it in 6 quarters since.
  • 174 funds tracked by Wall St. Rank held Aehr Test Systems as of Q3 2026.

Based on Arax Advisory Partners's 13F filing for Q3 2026, filed 12 Nov 2026.